CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?
Abstract
Authors
L.T. Burgers S.T. Nauta J.W. Deckers J.L. Severens W.K. Redekop